The Journal of Antibiotics · 2003 · 21 citations · 34 references
PharmacyMedicinal ChemistryPharmacologyChemotherapyDrug DiscoverySynthetic Medicinal ChemistryHeterocycle SynthesisHeterocyclic ChemistryMacrocycle SynthesisRetrosynthetic Analysis[2+2] Cycloaddition[4+2] CycloadditionAnthracycline-based ChemotherapyRing-closure ReactionsRing-forming Reactions
This paper focuses on study of second and third ring cyclization in anthracycline biosynthesis by a heterologous gene expression. Firstly, anthracycline non-producing Streptomyces peucetius mutant, D2 was heterologously complemented to produce daunomycins with plasmids pSgs44 and pSYE66, which contain putative cyclase genes of S. galilaeus and S. nogalater, respectively. A point mutation in the cyclase gene dpsY of D2 has changed glycine to serine resulting inactivation of the enzyme. Secondly, the putative cyclase gene snoaM from S. nogalater, was expressed in a gene cassette in S. lividans TK24 and S. coelicolor CH999 to study the influence of the cyclase gene on auramycinone production and the impact of endogenous genes on production profiles. The results obtained confirms that a cyclase closing the second and third ring of a polyketide is essential in anthracycline biosynthesis.
34
Molecular cloning: A laboratory manual
Prescott L. Deininger · Analytical Biochemistry · 1990 · 86.2K citations
Judith M. Ward, Gary R. Janssen, Tobias Kieser et al. · Molecular and General Genetics MGG · 1986 · 401 citations
‘Daunomycin’, a New Antibiotic of the Rhodomycin Group
A. DI MARCO, M. Gaetani, P. Orezzi et al. · Nature · 1964 · 251 citations